James A. Wachholz
Plus aucun poste en cours
Provenance du réseau au premier degré de James A. Wachholz
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
| Extinct | Pharmaceuticals: Major | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à James A. Wachholz via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MONSANTO | Wholesale Distributors | Corporate Officer/Principal | |
| Wake Forest School of Medicine | College/University | Doctorate Degree | |
| UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC. | Electronic Equipment/Instruments | Chairman | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BG MEDICINE, INC. | Medical Specialties | Corporate Officer/Principal | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
| Babson College | College/University | Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer | |
| ANAVEX LIFE SCIENCES CORP. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| Academy of Physicians In Clinical Research | Corporate Officer/Principal | ||
| Astra Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | ||
| CHROMADEX CORPORATION | Pharmaceuticals: Other | Director/Board Member | |
| WINSTON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| Ruth K. Broad Biomedical Research Foundation, Inc. | Director/Board Member | ||
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| University of Illinois College of Medicine | College/University | Doctorate Degree | |
| PHIO PHARMACEUTICALS CORP. | Biotechnology | Director/Board Member | |
Science Exchange, Inc.
 Science Exchange, Inc. Internet Software/ServicesTechnology Services Science Exchange, Inc. operates an online marketplace for outsourcing science experiments. The firm is a community marketplace for scientists to list, discover access, and pay for scientific services from institutions around the world. The company was founded by Elizabeth Iorns, Ryan Abbott and Daniel John Knox in 2011 and is headquartered in San Francisco, CA. | Internet Software/Services | Director/Board Member | |
Veristat LLC
 Veristat LLC BiotechnologyHealth Technology Veristat LLC engages in the provision of statistical and medical consulting services to the pharmaceutical and biotechnology industries. Its services include data management, biostatistics, statistical programming, medical writing, clinical monitoring, project management, regulatory submissions, and strategic consulting. The company was founded by Barbara Balser and John P. Balser in 1994 and is headquartered in Southborough, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Guardum Pharmaceuticals LLC
 Guardum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Pharmsynthez PJSC, Guardum Pharmaceuticals LLC produces pharmaceutical preparations. The company is based in Miami, FL. Guardum Pharmaceuticals was acquired by Pharmsynthez PJSC on April 18, 2013. | Pharmaceuticals: Major | Chief Executive Officer | |
| Georgetown University School of Medicine | College/University | Doctorate Degree | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
SciVac Ltd.
 SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | Biotechnology | Chief Executive Officer | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| C4 THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Sea Pharmaceuticals LLC
 Sea Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sea Pharmaceuticals LLC manufactures and markets pharmaceutical products and services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| VBI VACCINES INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Defender Pharmaceuticals, Inc. | Director/Board Member | ||
Clementia Pharmaceuticals USA, Inc.
 Clementia Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Clementia Pharmaceuticals USA, Inc. is a biopharmaceutical company that aims to improve health outcomes and create a positive impact for patients and society. The company is based in Newton, MA and focuses on developing innovative medicines in oncology, neuroscience, and rare diseases. Ipsen, the parent company, regularly plans and conducts informative and transparent events for the investor community. | Pharmaceuticals: Major | President | |
| CYCLERION THERAPEUTICS, INC. | Pharmaceuticals: Major | President | |
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Founder |
Statistiques
Internationale
| Etats-Unis | 46 |
| Israël | 3 |
| Royaume-Uni | 2 |
| Canada | 2 |
| Bermudes | 2 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 7 |
| Finance | 5 |
| Technology Services | 3 |
| Distribution Services | 2 |
Opérationnelle
| Director/Board Member | 57 |
| Chief Tech/Sci/R&D Officer | 38 |
| Corporate Officer/Principal | 32 |
| President | 20 |
| Undergraduate Degree | 17 |
Relations les plus connectées
| Insiders | |
|---|---|
| Trevor Phillips | 20 |
| Curtis Lockshin | 20 |
| Jim O'Shea | 16 |
| Angelos Stergiou | 13 |
| Donna Grogan | 12 |
| R. Scott Jones | 12 |
| William McVicar | 11 |
| David Redmond | 11 |
| James M. Roach | 11 |
| Paul D. Rubin | 10 |
| Samuel Duffey | 9 |
| Mark Currie | 9 |
| Alan M. Pearce | 7 |
| Louis Vaickus | 7 |
| Timothy G. Healey | 6 |
- Bourse
- Insiders
- James A. Wachholz
- Connexions Sociétés
